Endonovo Therapeutics Inc (ENDV)

[136]

That is fine with me. I am nicely above my average cost of my position now... and I see nothing but positive growth as long as the pre-clinical results are as great as we believe them to be based on the already verifiable information with the "rabbit study" etc.

As far as promising biotech stocks go, we are SUPER EARLY. It doesn't get much better than loading before pre-clinicals. There are only catalysts ahead and more exposure for ENDV.

Most wont even notice until this is bucking .25, .50, $1 ... JMHO

GLTY Neb, nice to have you here. Really appreciate the charts you share and perspective you give.